Last quarter (Q3 2023), Assembly Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Assembly Biosciences's net income was $-14.42M. See Assembly Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 153.00K	$ 153.00K	$ 6.25M	$ 79.11M	$ 15.96M	$ 14.80M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 153.00K	$ 153.00K	$ 142.00K	-	-	-
Operating Expense	$ 29.12M	$ 94.11M	$ -138.94M	$ 143.88M	$ 118.68M	$ 107.54M
Operating Income	$ -75.07M	$ -94.11M	$ -97.30M	$ -64.78M	$ -102.71M	$ -92.73M
Net Non Operating Interest Income Expense	$ 2.41M	$ 1.02M	$ 302.00K	$ 2.62M	$ 4.30M	$ 3.08M
Other Income Expense	-	-	$ -6.25M	-	$ 5.00K	-
Pretax Income	$ -72.66M	$ -93.09M	$ -132.39M	$ -62.15M	$ -98.41M	$ -89.65M
Tax Provision	-	-	$ -2.50M	$ 0.00	$ -774.00K	$ 1.10M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -72.66M	$ -93.09M	$ -129.85M	$ -62.15M	$ -97.63M	$ -90.75M
Basic EPS	$ -1.89	$ -1.92	$ -3.00	$ -1.75	$ -3.72	$ -3.98
Diluted EPS	$ -1.41	$ -1.92	$ -3.00	$ -1.75	$ -3.72	$ -3.98
Basic Average Shares	$ 204.25M	$ 48.41M	$ 43.28M	$ 35.43M	$ 26.26M	$ 22.80M
Diluted Average Shares	$ 204.25M	$ 48.41M	$ 43.28M	$ 35.43M	$ 26.26M	$ 22.80M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 29.12M	$ -94.11M	$ -138.94M	$ 143.88M	$ 118.68M	$ 107.54M
Net Income From Continuing And Discontinued Operation	$ -72.66M	$ -93.09M	$ -129.85M	$ -62.15M	$ -97.63M	$ -90.75M
Normalized Income	$ -11.39M	-	-	$ -62.15M	$ -97.63M	$ -90.75M
Interest Expense	-	-	-	-	-	-
EBIT	$ -73.24M	$ -93.09M	$ -132.39M	$ -64.78M	$ -102.71M	$ -92.73M
EBITDA	$ -73.37M	$ -92.44M	$ -131.33M	$ -64.08M	$ -102.22M	$ -92.09M

Currency in USD

Assembly Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing